Entera Bio Ltd.
ENTXNASDAQHealthcare● Active
$1.20
+$0.02(+1.69%)
Market Cap$59148240
P/E Ratio—
52W High$3.22
52W Low$0.91
Entera Bio Ltd. (ENTX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ENTX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.04M | $0.18M | $0.00M | $0.13M | $0.57M |
| Cost of Revenue | $0.04M | $0.17M | $0.06M | $0.17M | $0.37M |
| Gross Profit | $0.00M | $0.01M | ($0.06M) | ($0.03M) | $0.20M |
| Gross Margin %(computed) | 0.00% | 4.97% | — | -23.13% | 34.68% |
| Operating Expenses | |||||
| R&D Expenses | $6.00M | $4.50M | $4.45M | $5.78M | $6.77M |
| G&A Expenses | $5.53M | $5.09M | $0.00M | $0.00M | $5.69M |
| Total Operating Expenses | $11.53M | $9.59M | $8.88M | $13.04M | $12.41M |
| Operating Income | ($11.53M) | ($9.59M) | ($8.94M) | ($13.07M) | ($12.22M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.06M | $0.03M | $0.08M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.03M |
| Income Before Tax | ($11.44M) | ($9.53M) | ($8.86M) | ($12.93M) | ($12.25M) |
| Income Tax Expense | $0.00M | $0.01M | $0.03M | $0.14M | ($0.06M) |
| Net Income | ($11.44M) | ($9.54M) | ($8.89M) | ($13.07M) | ($12.19M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.25 | $-0.25 | $-0.31 | $-0.45 | $-0.47 |
| Wtd Avg Shares | 46.19M | 37.65M | 29.01M | 28.81M | 26.13M |
| EBITDA | ($11.50M) | ($9.54M) | ($8.80M) | ($12.87M) | ($12.16M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Entera Bio Ltd. data
About Entera Bio Ltd. (ENTX) Income Statement
Entera Bio Ltd. (ENTX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ENTX reported revenue of $0.00B, gross profit of $0.00B (gross margin 0.00%), and net income of ($0.01B) — a net profit margin of -27235.71%.
Frequently asked questions
ENTX · 4 questionsEntera Bio Ltd. (ENTX) reported revenue of $0.00B for 2025, down 76.8% year-over-year.
ENTX revenueENTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09